- Expanding their Pain Away product range into the New Zealand market through Chemist Warehouse
- There are over 50 Chemist Warehouse stores in New Zealand as of today
- Initially, there are 7 Pain Away products to be introduced to the New Zealand market through these Chemist Warehouse stores
- Further outlines the impact that current Chemist Warehouse director and also Wellnex director Mario Tascone is having on the company
- Chemist Warehouse are in the midst of an $8.8B RTO with Sigma, with a decision to be made by the ACCC in August
- If the Sigma + CW transaction does go ahead, around 90% of the combined entities earnings will come from Chemist Warehouse alone
- Gross profit margins have grown from 17% prior to last years Pain Away acquisition to over 33% currently
- 'Expanding into the New Zealand market is part of Wellnex Life's broader plan to grow its distribution channels and increase revenue'
Hopefully in the near future, we can have some numbers attached to what exactly this New Zealand deal encompasses for Wellnex, however the proof will be in the bottom line when figures are released come mid year.
In any case, the expansion of Wellnex continues - kudos to Mario Tascone and the gang for initiating this
